Monitoring tricyclic antidepressant therapy

Pharmacoeconomics. 1992 Feb;1(2):148-50. doi: 10.2165/00019053-199201020-00012.
No abstract available

MeSH terms

  • Antidepressive Agents, Tricyclic* / adverse effects
  • Antidepressive Agents, Tricyclic* / blood
  • Cost-Benefit Analysis
  • Depression / drug therapy*
  • Drug Monitoring* / economics
  • Humans

Substances

  • Antidepressive Agents, Tricyclic